About Lilium International Private Limited
Data last updated:
Lilium International Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36101MH2012PTC238751. Its GSTIN is 27AACCL4405B1Z2 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sujay Pramod Singh and Pramod Santbux Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 Shristi Plaza Near Hiranandani Business Park Sai Vihar Road Chandivali Powai, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹14 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹33.75 Lakh (net margin 2.4%) and EBITDA of ₹52.18 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 17% over five years.
Court records list 5 cases involving the company, including 5 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website liliuminternational.com.
Company details
Contact details
Lilium International Private Limited's registered office is in Mumbai, Maharashtra. Its website is liliuminternational.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address202 Shristi Plaza Near Hiranandani Business Park Sai Vihar Road Chandivali Powai, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lilium International Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lilium International is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lilium International Private Limited, buy the company report.
Financials of Lilium International Private Limited
FY 2025 filings availableLilium International Private Limited reported revenue of ₹14 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lilium International Private Limited, buy the company report.
Board of directors of Lilium International Private Limited
Lilium International has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujay Pramod Singh Also directs: Windlock Project Private Limited | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
| Pramod Santbux Singh | Director | 13 Dec 2012 | 13 Years 10 Months | Current |
Peer comparison
Lilium International Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fling Pharmaceuticals Private Limited | ₹14.1 Cr (FY 2024) | -21.0% | Thrissur, Kerala, India | |||
| Microwin Labs Private Limited | ₹14.05 Cr (FY 2024) | 61.0% | Mohali, Punjab, India | |||
| Functional Health Private Limited | ₹14.04 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| Lilium International Private Limitedthis company | ₹14 Cr (FY 2025) | ₹33.75 Lakh | 2.4% | -6.0% | Mumbai, Maharashtra, India | |
| Unjha Formulations Limited | ₹13.98 Cr (FY 2025) | -24.0% | Khali, Gujarat, India | |||
| Anicare Pharmaceuticals Private Limited | ₹13.97 Cr (FY 2025) | -31.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Lilium International Private Limited, buy the company report.
Auditor
Lilium International Private Limited is audited by M D M & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M D M & CO | FY 2022 | 114902W |
Shareholding
The shareholding of Lilium International Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lilium International Private Limited, buy the company report.
Legal cases
Lilium International Private Limited has 5 court cases on record: 5 filed by Lilium International. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Maersk Line India Pvt. Ltd. and 1 other | Disposed |
| Bombay High Court | Commercial suit | Filed by the company against Maersk Line India Pvt. Ltd. and 1 other | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| Bombay High Court | Court case (LPETN) | Filed by the company against an individual | Disposed |
To see the full case history of Lilium International Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lilium International Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lilium International has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCL4405B1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lilium International Private Limited, buy the company report.
Recent activity
Lilium International Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Umeshkumar Gorakhnath Singh ceased to be Director on 25 Mar 2022.
Frequently asked questions
Lilium International is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 December 2012 (14+ years old) and is registered under CIN U36101MH2012PTC238751.
Lilium International has 2 current directors:
- Sujay Pramod Singh - Director
- Pramod Santbux Singh - Director
The latest financial statements of Lilium International on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lilium International is 27AACCL4405B1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lilium International is U36101MH2012PTC238751. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lilium International has 5 court cases on record: 5 filed by the company. Most are in the district courts.
Lilium International was incorporated on 13 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Lilium International by revenue are Fling Pharmaceuticals Private Limited, Microwin Labs Private Limited, Functional Health Private Limited, Unjha Formulations Limited, Anicare Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Umeshkumar Gorakhnath Singh ceased to be Director on 25 Mar 2022. Sujay Pramod Singh was appointed as Director on 22 Jun 2020. Sujay Pramod Singh ceased to be Additional Director on 22 Jun 2020. Lilium International has 4 board changes on record in total.
Lilium International can be reached through the website liliuminternational.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Lilium International is at 202 Shristi Plaza Near Hiranandani Business Park Sai Vihar Road Chandivali Powai, Mumbai, Maharashtra, India – 400072.